Dana Faber Cancer Institute/ Boston Children's Hospital — Boston, Massachusetts

Dana Faber Cancer Institute/ Boston Children's Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana Faber Cancer Institute/ Boston Children's Hospital has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: B-cell Acute Lymphoblastic Leukemia.

Sponsors: Pediatric Transplantation & Cellular Therapy Consortium.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Faber Cancer Institute/ Boston Children's Hospital?

Dana Faber Cancer Institute/ Boston Children's Hospital has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Faber Cancer Institute/ Boston Children's Hospital conducted?

Dana Faber Cancer Institute/ Boston Children's Hospital has 1 clinical trials on record, with 1 currently active. Their work covers B-cell Acute Lymphoblastic Leukemia.

Is Dana Faber Cancer Institute/ Boston Children's Hospital accredited by Crixeo Clinical Trials?

Dana Faber Cancer Institute/ Boston Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Faber Cancer Institute/ Boston Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.